Image: shutterstock
Despite conflicting reports that have circulated, a clinical trial in humans testing an mRNA vaccine to prevent infection with the new coronavirus has begun in Seattle, after a similar trial in mice was completed. According to the US National Institute of Allergy and Infectious Diseases, the mRNA-1273 vaccine succeeded in triggering an effective antibody immune response in mice. According to the institute, further trials in mice and primates will continue alongside the clinical studies in humans.
EARA News Digest
Translation: Let the Patients Live